Ultrasound–triggered tumor-selective nitric oxide release enhances tumor penetration of antibody–conjugated nanomedicine
Xiaodong Wang , Ruifeng Duan , Xin Chen , Tongjun Liu , Zhilin Liu
Interdisciplinary Medicine ›› 2026, Vol. 4 ›› Issue (3) : e70117
The tumor vascular barrier restricts the penetration of antibody-conjugated nanomedicine, severely limiting its therapeutic efficacy. Selective delivery of nitric oxide (NO) to tumors can modulate vascular permeability, thereby enhancing the penetration of antibody-conjugated nanomedicine. Herein, we developed an ultrasound-responsive NO-releasing material, named HA-SNO, based on a hyaluronic acid backbone, which releases NO upon exposure to ultrasound waves. After systemic administration of HA-SNO, tumor-localized release of NO was achieved using a focused ultrasound system operating at a low intensity (1 MHz, 2.0 W/cm2, 50% duty cycle). The released NO induced vasodilation and disrupted the tumor vascular barrier, thereby promoting extravasation and more homogeneous intratumoral distribution of HER2-targeted antibody–conjugated nanomedicine (HER2–SN38). This strategy exhibited significantly enhanced anti-tumor efficacy, with a tumor inhibition rate of 97.67%. These findings highlight the potential clinical utility of ultrasound-triggered tumor-selective delivery of NO in overcoming vascular barriers to drug delivery.
antibody–conjugated nanomedicine / focused ultrasound / nitric oxide–donor nanomedicine / tumor penetration / tumor-selective release
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
2026 The Author(s). Interdisciplinary Medicine published by Wiley-VCH GmbH on behalf of Nanfang Hospital, Southern Medical University.
/
| 〈 |
|
〉 |